Wendy Hauck

Company: Eisai

Job title: Global Associate Medical Director, Women’s Cancer Care

Seminars:

Progress in Anti-HER2 Agents & Combination 3:00 pm

• Understanding the line of therapy considerations • Discussing the standard of care and how it differs between indications • Chemo with antiengiogenics with immune therapy • Latest results and directions • Antiangeogenic and chemotherapyRead more

day: Day One